1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency : The IMCA1 Study of the EARCO Clinical Research Collaboration
(
- Contribution to journal › Letter
- 2017
-
Mark
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency : an open-label extension trial (RAPID-OLE)
(
- Contribution to journal › Article